DE MICCO, ROSA
 Distribuzione geografica
Continente #
EU - Europa 4.406
AS - Asia 2.069
NA - Nord America 1.454
SA - Sud America 306
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 8.274
Nazione #
RU - Federazione Russa 3.294
US - Stati Uniti d'America 1.417
SG - Singapore 733
CN - Cina 429
IE - Irlanda 340
IT - Italia 310
HK - Hong Kong 281
VN - Vietnam 273
BR - Brasile 262
DE - Germania 116
KR - Corea 116
GB - Regno Unito 93
JP - Giappone 81
FR - Francia 59
IN - India 54
UA - Ucraina 44
SE - Svezia 28
TR - Turchia 28
FI - Finlandia 24
GR - Grecia 23
AR - Argentina 18
CA - Canada 18
NL - Olanda 15
AT - Austria 14
ZA - Sudafrica 14
MX - Messico 13
PL - Polonia 12
CZ - Repubblica Ceca 11
ID - Indonesia 10
IQ - Iraq 9
UZ - Uzbekistan 9
CO - Colombia 8
MA - Marocco 8
BD - Bangladesh 7
JO - Giordania 7
PK - Pakistan 7
EC - Ecuador 5
ES - Italia 5
RO - Romania 5
BE - Belgio 4
KE - Kenya 4
PE - Perù 4
PH - Filippine 4
AZ - Azerbaigian 3
EG - Egitto 3
KZ - Kazakistan 3
LT - Lituania 3
TN - Tunisia 3
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
NP - Nepal 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
KW - Kuwait 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
TM - Turkmenistan 1
Totale 8.274
Città #
Moscow 1.195
Singapore 384
Dublin 340
Hong Kong 277
San Jose 269
Santa Clara 268
Seoul 115
Ashburn 109
Hefei 98
Ho Chi Minh City 87
Jacksonville 76
Naples 69
New York 69
Hanoi 64
Chandler 56
Beijing 48
Bengaluru 44
Princeton 34
Bremen 32
Roxbury 32
Munich 30
The Dalles 26
São Paulo 25
Los Angeles 24
Medford 23
Napoli 18
Da Nang 17
Caserta 14
Cambridge 12
Haiphong 12
London 12
Rome 12
Wilmington 12
Boardman 11
Helsinki 11
Warsaw 11
Avella 10
Dallas 10
Falkenstein 10
Istanbul 10
Nuremberg 10
Reggio Emilia 10
Brno 9
Des Moines 9
Frankfurt am Main 9
Orem 9
Tashkent 9
Amsterdam 8
Amman 7
Ann Arbor 7
Curitiba 7
Jinan 7
Johannesburg 7
Manchester 7
Nanjing 7
Norwalk 7
Aversa 6
Biên Hòa 6
Hải Dương 6
Milan 6
Ninh Bình 6
Rio de Janeiro 6
Shanghai 6
Stockholm 6
Thái Bình 6
Tokyo 6
Turku 6
Vienna 6
Viterbo 6
Casoria 5
Montreal 5
Phoenix 5
Quận Ba 5
Trento 5
Woodbridge 5
Zhengzhou 5
Belo Horizonte 4
Bogotá 4
Boston 4
Cape Town 4
Casablanca 4
Chennai 4
Ercolano 4
Ha Long 4
Hangzhou 4
Hillsboro 4
Lima 4
Nairobi 4
Nha Trang 4
Ningbo 4
Porto Alegre 4
Sacramento 4
Salvador 4
San Francisco 4
Shenzhen 4
Tiền Hải 4
Vũng Tàu 4
Acerra 3
Afragola 3
Athens 3
Totale 4.311
Nome #
A transient third cranial nerve palsy as presenting sign of spontaneous intracranial hypotension 182
Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients 170
Clinical correlations of microstructural changes in progressive supranuclear palsy 161
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 153
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 151
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 149
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 144
Medical retrofitting design 144
Central pain processing in "drug-naïve" pain-free patients with Parkinson's disease 143
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 140
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders 140
Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study 140
Fatigue in Parkinson's disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach 134
Altered domain-specific striatal functional connectivity in patients with Parkinson's disease and urinary symptoms 132
Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. 132
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study 128
Olfactory loss and brain connectivity after COVID-19 124
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 121
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 121
Olfactory Loss and Brain Connectivity after COVID-19: Structural Follow-Up at One Year 119
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 115
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 114
Fatigue in Parkinson's disease: A systematic review and meta-analysis 114
Functional connectivity underpinnings of fatigue in "Drug-Naïve" patients with Parkinson's disease 113
Memory Phenotypes In Early, De Novo Parkinson's Disease Patients with Mild Cognitive Impairment 112
Connectivity Correlates of Anxiety Symptoms in Drug-Naive Parkinson's Disease Patients 112
Brain Networks and Cognitive Impairment in Parkinson's Disease 110
Correction to: Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 109
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson's disease patients: a prospective longitudinal study 109
Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease 109
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 109
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 107
A Novel Compound Heterozygous Mutation in Aprataxin Causes Slowly Progressive Ataxia without Oculomotor Apraxia 106
Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease 106
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 105
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 105
Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study 102
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease 102
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 100
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 99
Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients 99
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 97
Correlates of psychological distress in epileptic patients during the COVID-19 outbreak 96
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 95
Sex-related pattern of intrinsic brain connectivity in drug-naïve Parkinson's disease patients 94
The psychological correlates of fatigue in Parkinson's disease: Contribution of maladaptive metacognitive beliefs 90
Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study 89
Can we predict development of impulsive–compulsive behaviours in Parkinson’s disease? 88
Clinical correlates of “pure” essential tremor: the TITAN study 87
Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension 87
Kufor Rakeb syndrome without gaze palsy and pyramidal signs due to novel ATP13A2 mutations 86
Flexible brain dynamics underpins complex behaviours as observed in Parkinson's disease 84
Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment 82
Structural MRI in Idiopathic Parkinson's Disease 81
Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue 81
Validation of the Italian version of the PSP Quality of Life questionnaire 80
Subjective memory decline in Parkinson's disease patients with and without fatigue 79
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum 78
Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 Outbreak 78
Speech Rhythm Variation in Early-Stage Parkinson's Disease: A Study on Different Speaking Tasks 77
Family History in Parkinson's Disease: A National Cross‐Sectional Study 75
Functional Connectivity Signatures of Parkinson's Disease 75
The Italian tremor Network (TITAN): rationale, design and preliminary findings 73
Pain and fatigue in Parkinson's disease: advances in diagnosis and management 72
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 71
A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network 70
Distinctive Handwriting Signs in Early Parkinson’s Disease 70
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurology 68
A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP‐NET 67
Functional motor phenotypes: to lump or to split? 66
Impulse control behaviors in Parkinson's disease: Drugs or disease? Contribution from imaging studies 66
Early classification of functional connectomes in Parkinson’s disease: a comparison of machine learning classifiers using multi-scale topological features 65
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 65
Editorial: Non-motor Symptoms in Primary Motor Neurological Disorders: From Molecular Pathways to Clinical and Therapeutic Implications 64
HPDL Biallelic Variants in Cerebral Palsy and Childhood‐Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights 64
Molecular Imaging Markers to Track Huntington’s Disease Pathology 64
Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients 63
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 62
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study 60
Analyzing Information Exchange in Parkinson’s Disease via Eigenvector Centrality: A Source-Level Magnetoencephalography Study 59
Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age 59
REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease 57
Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients 53
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa–Carbidopa Intestinal Gel: A Nation‐Wide, Multicenter, Longitudinal, “Real‐World” Study. The EPIC Study 44
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET 39
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 38
Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease 37
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders 33
Totale 8.413
Categoria #
all - tutte 25.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 9 24 3
2021/2022244 9 9 1 10 70 4 6 8 13 21 25 68
2022/2023483 43 8 6 23 53 19 2 13 292 13 5 6
2023/2024374 28 16 18 17 110 79 9 5 1 8 27 56
2024/20251.233 8 28 7 29 226 181 169 132 162 103 91 97
2025/20265.661 244 392 250 291 448 3.079 341 227 210 179 0 0
Totale 8.413